2‐Heteroaryl‐[1,2,4]triazolo[1,5‐<i>c</i>]quinazoline‐5(6 H)‐thiones and Their S‐Substituted Derivatives: Synthesis, Spectroscopic Data, and Biological ActivityA. K. Bilyi, С. І. Коваленко, V. V. Ivchuk et al.|ChemPlusChem|2015Cited by 29
In Silico Identification and Characterization of Spiro[1,2,4]triazolo[1,5-c]quinazolines as Diacylglycerol Kinase α ModulatorsLyudmyla Antypenko, С. І. Коваленко, Kostiantyn Shabelnyk et al.|Molecules|2025Cited by 6
Search for Potential Neuroprotectors for Correction of Cognitive and Behavioral Disorders After Ketamine Anesthesia Among 2′-R-6’H-Spiro(cycloalkyl-, heterocyclyl)[1,2, 4]triazolo[1,5-C]-Quinazolines: Fragment-Oriented Design, Molecular Docking, ADMET, Synthesis and <i>In Vivo</i> StudyKostiantyn Shabelnyk, С. І. Коваленко, Lyudmyla Antypenko et al.|Preprints.org|2025Cited by 1
In Silico Identification and Characterization of Spiro [1,2,4]triazolo[1,5-<i>c</i>]quinazolines as Diacylglycerol Kinase α ModulatorsLyudmyla Antypenko, С. І. Коваленко, Valentyn Oksenych et al.|Preprints.org|2025Cited by 1
Discovery and Characterization of Novel Spirotriazoloquinazolines as Potential Neuroprotectors: Synthesis, Computational Screening, and Preliminary In Vivo EvaluationKostiantyn Shabelnyk, Serhii Kovalenko, Igor Belenichev et al.|Journal of Neurochemistry|2026Cited by 0